Press release - 30/05/2012 Valuable Discussions at the Third International DDI Workshop The organisation team of the Third International DDI (drug-drug interactions) Workshop has expressed great satisfaction with the course of the scientific meeting. The participants of the DDI Workshop commended the very high scientific level of the presentations and valuable and inspiring discussions of the different topics. Without a doubt, the DDI Workshop at Marbach Castle is a well established platform for the annual exchange between experts,…https://www.gesundheitsindustrie-bw.de/en/article/press-release/valuable-discussions-at-the-third-international-ddi-workshop
Article - 29/05/2012 David Schleheck: exploring the effective degradation of surfactants David Schleheck biologist at the University of Konstanz focuses on the bacterial degradation of surfactants and LAS in particular. The results of his research are of huge importance for the recycling of grey water in areas including home sewage treatment systems for example.https://www.gesundheitsindustrie-bw.de/en/article/news/david-schleheck-exploring-the-effective-degradation-of-surfactants
Article - 29/05/2012 Exploring special antibiotics synthesis pathways Kirromycin, an antibiotic produced by soil bacteria, reveals unusual steps for biosynthesis that might also be of interest for biotechnological applications. Dr. Ewa Maria Musiol was the first to shed light on the functions of specific acyltransferases involved in the biosynthesis of the antibiotic. She also received the 2012 DECHEMA PhD Award for Natural Products Research for these achievements.https://www.gesundheitsindustrie-bw.de/en/article/news/exploring-special-antibiotics-synthesis-pathways
Article - 29/05/2012 Isabelle Seemann: DNA as building block for nanostructures Since the emergence of nanotechnology in the 1980s DNA has been used as a construction material in many areas. Wires grids and nanorobots can all be produced from this versatile material. Isabelle Seemann scientist at the University of Konstanz works with a particular DNA constellation known as three-way DNA junction. Seemanns findings are of great importance for different areas of knowledge including the material sciences analytics and…https://www.gesundheitsindustrie-bw.de/en/article/news/isabelle-seemann-dna-as-building-block-for-nanostructures
Article - 29/05/2012 Intestinal bacteria and human gut types The type of bacteria that colonize the human gut does not just influence our digestion and well-being. Metagenome sequencing has provided an international consortium involving scientists from the European Molecular Biology Laboratory at the University Hospital of Heidelberg with evidence that certain individuals have different gut types with different types of bacteria. Such individuals not only differ in their predisposition to disease, but also…https://www.gesundheitsindustrie-bw.de/en/article/news/intestinal-bacteria-and-human-gut-types
Dossier - 24/05/2012 Biochips: microsystems technology for the life sciences Nanoscale robots and intelligent measurement systems in arteries, fingernail-sized DNA chips that can be used to analyze thousands of genes in tiny samples, intelligent DNA microsensors – the trend in the life sciences is moving towards miniaturization in all areas including electronics, sensor systems and the handling of liquids. Over the last few years, a research area with growing potential has developed at the interface of physics, the…https://www.gesundheitsindustrie-bw.de/en/article/dossier/biochips-microsystems-technology-for-the-life-sciences
Press release - 24/05/2012 Jiangsu Life Science and Technology Innovation Park The park is still under construction (first construction phase finished in autumn 2012). Located in Xianlin University Town, East of Nanjing Center, it is in the immediate neighborhood of the new campuses of Nanjing University, Nanjing Normal University, Nanjing University of Traditional Chinese Medicine and China Pharmaceutical University. https://www.gesundheitsindustrie-bw.de/en/article/press-release/jiangsu-life-science-and-technology-innovation-park
Press release - 23/05/2012 GlaxoSmithKline to fully acquire Cellzome for 99 million U.S. dollar GlaxoSmithKline plc (GSK) announced that it has entered into an agreement to acquire those shares it does not currently own in Cellzome, a leader in the development and advancement of proteomics technologies, for £61 million (US$99 million) in cash. Cellzome, a privately owned company with laboratories in Cambridge, UK, and Heidelberg, Germany, will become part of GSK’s R&D organisation.https://www.gesundheitsindustrie-bw.de/en/article/press-release/glaxosmithkline-to-fully-acquire-cellzome-for-99-million-u-s-dollar
Press release - 22/05/2012 Rare neurons discovered in monkey brains Henry Evrard neuroanatomist at the Max Planck Institute for Biological Cybernetics in Tübingen Germany now discovered that von Economo neurons VEN occur in the insula of macaque monkeys. The morphology size and distribution of the monkey VEN suggest that it is at least a primal anatomical homolog of the human VEN. This finding offers new and much-needed opportunities to examine in detail the connections and functions of a cell and brain region…https://www.gesundheitsindustrie-bw.de/en/article/press-release/rare-neurons-discovered-in-monkey-brains
Press release - 22/05/2012 Microscope looks into cells of living fish Microscopes provide valuable insights in the structure and dynamics of cells, in particular when the latter remain in their natural environment. However, this is very difficult especially for higher organisms. Researchers of Karlsruhe Institute of Technology (KIT), the Max Planck Institute for Polymer Research, Mainz, and the American National Institutes of Health (NIH) have now developed a new method to visualize cell structures of an eighth of…https://www.gesundheitsindustrie-bw.de/en/article/press-release/microscope-looks-into-cells-of-living-fish
Press release - 22/05/2012 Risk assessment of nano-materials Nano-particles (Greek: nanos = dwarf) are now being used to create fascinating products with totally new functionalities. These include textiles from which dirt simply runs off or which have an anti-bacterial effect. But as is the case with every new technology, this one must also be safe to use. It is therefore of interest to both manufacturers and users of such high-tech products that nano-particles are harmless for both human beings and the…https://www.gesundheitsindustrie-bw.de/en/article/press-release/risk-assessment-of-nano-materials
Article - 21/05/2012 Microchip facilitates bowel movements Faecal incontinence is a common problem, but is still a strong taboo. A small microchip, implanted above the sacral bone, promises to make sufferers’ lives a lot easier. Sacral nerve stimulation (SNS) not only restores patients’ ability to control defaecation, but also provides new insights into the innervation and physiology of the bowel and the pelvic floor.https://www.gesundheitsindustrie-bw.de/en/article/news/microchip-facilitates-bowel-movements
Article - 21/05/2012 Interactions between the genome and the environment Parental neglect appears to lead to epigenetic changes in children, which result in behavioural problems in later years. This is one issue amongst the many that were addressed at the colloquium “Gene und Umwelt – Wie wir werden, was wir sind” (Genes and the environment – how we become what we are) recently organized by the Daimler and Benz Foundation in Berlin.https://www.gesundheitsindustrie-bw.de/en/article/news/interactions-between-the-genome-and-the-environment
Article - 21/05/2012 Kathrin Thedieck – the art of deciphering signalling The molecule mTOR is one of the most important cellular switch centres it controls cellular growth in relation to the availability of nutrients and also plays a key role in the pathogenesis of cancer neurodegenerative diseases and ageing. Dr. Kathrin Thedieck from the Institute of Biology III at the University of Freiburg is interested in solving the question as to how insulin growth factors or nutrients such as amino acids influence the complex…https://www.gesundheitsindustrie-bw.de/en/article/news/kathrin-thedieck-the-art-of-deciphering-signalling
Press release - 16/05/2012 Ray of hope for millions of patients The 2012 Innovation Award of the biotechnology regions in Germany was presented to Prof. Ulrich Schraermeyer on 9 May 2012 in Frankfurt am Main. The Tübingen-based researcher received the award in recognition of his idea to use an active substance to treat the dry form of age-related macular degeneration (AMD). This impedes a patient’s ability to see and can ultimately lead to complete blindness. In the interest of those affected by the disease,…https://www.gesundheitsindustrie-bw.de/en/article/press-release/ray-of-hope-for-millions-of-patients
Press release - 16/05/2012 OGpharma in China OGpharma (CEO: Dr. Wanzhou ZHAO) is a Contract Research Company (CRO) located in Nanjing’s Gulou Science Park. The company offers two services: a) contract research, and b) consulting service for international cooperation.https://www.gesundheitsindustrie-bw.de/en/article/press-release/ogpharma-in-china
Article - 14/05/2012 Biogas and sustainability The German Renewable Energy Sources Act (EEG) has led to a considerable increase in the use of biogas in Germany. However, increasing biogas production must make ecological sense and not generate conflict with the sustainability objectives of environmental conservation schemes. There must therefore be a careful consideration of the overall conditions. An analysis of the ecological impact of the generation and use of biogas in Germany taking into…https://www.gesundheitsindustrie-bw.de/en/article/news/biogas-and-sustainability
Press release - 10/05/2012 BVMed propounds Annual Report The German Medical Technology Association BVMed advocates for a better coordination and promotion of advances in medical technology. BVMed the German Medical Technology Association represents more than 230 manufacturers and trade companies in the medical technology sector. Medtech production amounts to about 20 billion euros with 175.000 employees in Germany. https://www.gesundheitsindustrie-bw.de/en/article/press-release/bvmed-propounds-annual-report
Press release - 10/05/2012 FANCM gene plays key role in inheritance Scientists of KIT and the University of Birmingham have identified relevant new functions of a gene that plays a crucial role in Fanconi anemia, a life-threatening disease. The FANCM gene is known to be important for the stability of the genome. Now, the researchers found that FANCM also plays a key role in the recombination of genetic information during inheritance. For their studies, the scientists used thale cress as a model plant. Their…https://www.gesundheitsindustrie-bw.de/en/article/press-release/fancm-gene-plays-key-role-in-inheritance
Press release - 08/05/2012 BIOPRO Baden-Württemberg: 10 years More than 120 invited guests came to Stuttgart on 2nd May 2012 to discuss the potential of biotechnology in Baden-Württemberg – and to celebrate! Speakers praised BIOPRO and entertained the audience with anecdotes about the last 10 years as well as congratulating Dr. Ralf Kindervater, CEO of BIOPRO Baden-Württemberg GmbH, for the committed and sustainable work his organization has done over the last ten years.https://www.gesundheitsindustrie-bw.de/en/article/press-release/biopro-baden-wuerttemberg-10-years
Press release - 04/05/2012 Novaliq receives €3.9 million in further round of financing talks Novaliq GmbH, a drug delivery company focusing on difficult to dissolve substances for ophthalmic and dermatological applications, announced the conclusion of a round of financing talks resulting in €3.9 million.https://www.gesundheitsindustrie-bw.de/en/article/press-release/novaliq-receives-3-9-million-in-further-round-of-financing-talks
Guest article - 30/04/2012 First-hand experience: report from a scholarship programme in Nanjing Simon Felz participated in a scholarship programme run by the Baden-Württemberg Ministry of Science, Research and the Arts that made it possible for him to spend six months in a laboratory at Nanjing University. Here he tells us about his experience in China. https://www.gesundheitsindustrie-bw.de/en/article/news/first-hand-experience-report-from-a-scholarship-programme-in-nanjing
Article - 30/04/2012 Antibiotic resistance in hospitals There is an alarming rise in infections caused by bacteria that are resistant to common antibiotics. A particular problem is nosocomial (hospital-acquired) infections of newborns, for which a Germany-wide surveillance system has been established. Novel natural substances with an antibiotic effect might be able to contain the danger.https://www.gesundheitsindustrie-bw.de/en/article/news/antibiotic-resistance-in-hospitals
Guest article - 30/04/2012 First-hand experience: what it is like to do an internship at Boehringer Ingelheim in Shanghai Diana Schwarz is studying bioengineering at the Karlsruhe Institute of Technology (KIT) and also did a practical internship at Boehringer Ingelheim in Shanghai. Here she reports on her stay abroad.https://www.gesundheitsindustrie-bw.de/en/article/news/first-hand-experience-what-it-is-like-to-do-an-internship-at-boehringer-ingelheim-in-shanghai